Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daryl J Hoban

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Clinical Cornerstone|March 3, 2004
Antibiotics and collateral damageDaryl J Hoban
Drug Design, Development and Therapy|December 6, 2019
Clinical And Bacteriological Impact Of Clarithromycin In Streptococcal Pharyngitis: Findings From A Meta-Analysis Of Clinical TrialsDaryl J Hoban, Jos Nauta
Expert Opinion on Pharmacotherapy|February 28, 2002
Ketolides in the treatment of respiratory infectionsGeorge G Zhanel, Daryl J Hoban
Diagnostic Microbiology and Infectious Disease|March 1, 2011
Introduction to the CANWARD Study (2007-2009)Daryl J Hoban, George G Zhanel
Expert Review of Anti-Infective Therapy|December 22, 2006
Clinical implications of macrolide resistance in community-acquired respiratory tract infectionsDaryl J Hoban, George G Zhanel
The Journal of Antimicrobial Chemotherapy|May 31, 2013
Introduction to the CANWARD study (2007–11)Daryl J Hoban, George G Zhanel
The Journal of Antimicrobial Chemotherapy|July 12, 2005
Mechanisms of resistance to telithromycin in Streptococcus pneumoniaeTamiko Hisanaga, Daryl J Hoban, George G Zhanel
Antimicrobial Agents and Chemotherapy|September 18, 2002
Penicillin-binding protein 1A, 2B, and 2X alterations in Canadian isolates of penicillin-resistant Streptococcus pneumoniaeKimberly A Nichol, George G Zhanel, Daryl J Hoban
The New England Journal of Medicine|July 10, 2002
Resistance to levofloxacin and failure of treatment of pneumococcal pneumoniaGeorge G Zhanel, Daryl J Hoban, Charles K Chan
International Journal of Antimicrobial Agents|July 28, 2005
Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoniaeAyman M Noreddin, Daryl J Hoban, George G Zhanel
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Clinical Cornerstone|March 3, 2004
Antibiotics and collateral damageDaryl J Hoban
Drug Design, Development and Therapy|December 6, 2019
Clinical And Bacteriological Impact Of Clarithromycin In Streptococcal Pharyngitis: Findings From A Meta-Analysis Of Clinical TrialsDaryl J Hoban, Jos Nauta
Expert Opinion on Pharmacotherapy|February 28, 2002
Ketolides in the treatment of respiratory infectionsGeorge G Zhanel, Daryl J Hoban
Diagnostic Microbiology and Infectious Disease|March 1, 2011
Introduction to the CANWARD Study (2007-2009)Daryl J Hoban, George G Zhanel
Expert Review of Anti-Infective Therapy|December 22, 2006
Clinical implications of macrolide resistance in community-acquired respiratory tract infectionsDaryl J Hoban, George G Zhanel
The Journal of Antimicrobial Chemotherapy|May 31, 2013
Introduction to the CANWARD study (2007–11)Daryl J Hoban, George G Zhanel
The Journal of Antimicrobial Chemotherapy|July 12, 2005
Mechanisms of resistance to telithromycin in Streptococcus pneumoniaeTamiko Hisanaga, Daryl J Hoban, George G Zhanel
Antimicrobial Agents and Chemotherapy|September 18, 2002
Penicillin-binding protein 1A, 2B, and 2X alterations in Canadian isolates of penicillin-resistant Streptococcus pneumoniaeKimberly A Nichol, George G Zhanel, Daryl J Hoban
The New England Journal of Medicine|July 10, 2002
Resistance to levofloxacin and failure of treatment of pneumococcal pneumoniaGeorge G Zhanel, Daryl J Hoban, Charles K Chan
International Journal of Antimicrobial Agents|July 28, 2005
Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoniaeAyman M Noreddin, Daryl J Hoban, George G Zhanel
Pageof 18